126 related articles for article (PubMed ID: 10444318)
1. Risk factors for death in hospitalized dysentery patients in Rwanda.
Legros D; Paquet C; Dorlencourt F; Saoult E
Trop Med Int Health; 1999 Jun; 4(6):428-32. PubMed ID: 10444318
[TBL] [Abstract][Full Text] [Related]
2. [An outbreak of Shigella dysenteriae type 1 dysentery in a refugee camp in Rwanda].
Paquet C; Leborgne P; Sasse A; Varaine F
Sante; 1995; 5(3):181-4. PubMed ID: 7640901
[TBL] [Abstract][Full Text] [Related]
3. Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults.
Rogerie F; Ott D; Vandepitte J; Verbist L; Lemmens P; Habiyaremye I
Antimicrob Agents Chemother; 1986 May; 29(5):883-6. PubMed ID: 3524434
[TBL] [Abstract][Full Text] [Related]
4. Shigella dysenteriae serotype 1 in west Africa: intervention strategy for an outbreak in Sierra Leone.
Guerin PJ; Brasher C; Baron E; Mic D; Grimont F; Ryan M; Aavitsland P; Legros D
Lancet; 2003 Aug; 362(9385):705-6. PubMed ID: 12957094
[TBL] [Abstract][Full Text] [Related]
5. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
Engels D; Madaras T; Nyandwi S; Murray J
Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
[TBL] [Abstract][Full Text] [Related]
6. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
[TBL] [Abstract][Full Text] [Related]
7. [Ciprofloxacin in the treatment of dysentery caused by type 1 Shigella dysenteriae during an epidemic in Rwandan refugees in Goma in 1994].
Laureillard D; Paquet C; Malvy D
Sante; 1998; 8(4):303-5. PubMed ID: 9794043
[TBL] [Abstract][Full Text] [Related]
8. Hospitalized dysentery cases during an outbreak of Shigella dysenteriae type I: Ndanga District Hospital, Zimbabwe.
Mudzamiri WS; L'Herminez M; Peterson DE; Nhindiri P
Cent Afr J Med; 1996 Jun; 42(6):177-9. PubMed ID: 8870316
[TBL] [Abstract][Full Text] [Related]
9. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
[TBL] [Abstract][Full Text] [Related]
10. Outbreak of dysentery due to nalidixic acid resistant S. dysenteriae 1 at Agartala, Tripura: a hospital based study.
Datta P; Sen D
Indian J Public Health; 1990; 34(1):11-4. PubMed ID: 2101382
[TBL] [Abstract][Full Text] [Related]
11. Case management of a multidrug-resistant Shigella dysenteriae serotype 1 outbreak in a crisis context in Sierra Leone, 1999-2000.
Guerin PJ; Brasher C; Baron E; Mic D; Grimont F; Ryan M; Aavitsland P; Legros D
Trans R Soc Trop Med Hyg; 2004 Nov; 98(11):635-43. PubMed ID: 15363643
[TBL] [Abstract][Full Text] [Related]
12. Epidemic shigella dysentery in children in northern KwaZulu-Natal.
Chopra M; Wilkinson D; Stirling S
S Afr Med J; 1997 Jan; 87(1):48-51. PubMed ID: 9063314
[TBL] [Abstract][Full Text] [Related]
13. International note. Antibiotics in the management of shigellosis.
Can Commun Dis Rep; 2004 Dec; 30(23):202-3. PubMed ID: 15603533
[No Abstract] [Full Text] [Related]
14. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
[TBL] [Abstract][Full Text] [Related]
15. Antibiotics in the management of shigellosis.
Wkly Epidemiol Rec; 2004 Sep; 79(39):355-6. PubMed ID: 15571173
[No Abstract] [Full Text] [Related]
16. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
Cheasty T; Skinner JA; Rowe B; Threlfall EJ
Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
[TBL] [Abstract][Full Text] [Related]
17. Nalidixic-acid-resistant Shigella dysenteriae I.
Panhotra BR; Desai B; Sharma PL
Lancet; 1985 Mar; 1(8431):763. PubMed ID: 2858035
[No Abstract] [Full Text] [Related]
18. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group
Pediatr Infect Dis J; 2002 Dec; 21(12):1136-41. PubMed ID: 12488664
[TBL] [Abstract][Full Text] [Related]
19. Nalidixic acid in Shigella dysenteriae outbreaks.
Malengreau M
Lancet; 1984 Jul; 2(8395):172. PubMed ID: 6146074
[No Abstract] [Full Text] [Related]
20. [Short-term ciprofloxacin treatment of bacillary dysentery due to Shigella dysenteriae type 1 in Rwandan refugees].
Soares JL; Arendt V; Coue JC; Milleliri JM; Philips B; Regis R; Mérouze F; Rey JL
Med Trop (Mars); 1994; 54(4):319-23. PubMed ID: 7746123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
